![]() |
![]() | ![]() |
We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
![]()
Eternal Technologies Group, Inc. (OTCBB ETLT): invested in and carried out the world's first mass embryo transfer project for 10,000 fine-breeding sheep embryos. Through the successful completion of this major milestone, ELTS gathered recognition in the industry and has maintained strong momentum in grown since then. ETLT is engaged in commercialization of newly developed technologies in genetic engineering, and biomedical research, which is based on research, development and application of bioengineering technologies. The Company constructs three platforms, i.e. industrialized embryo transfer, large-scale improvement of herds, and production of new medical products. The Company makes use of its technology and geographical advantages to promote its share in the market at very early stage so that it receives larger margin of return from hi-techs and maximizes the ROI for its investors. Website: eternaltechs.com .. See also: embryochina.com | ||||||||||||||
|
Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
© 2023 Knight Sac Media. Data provided by IEX, Alpha Vantage, Coinbase, Binance, Fintel and CityFALCON News |